IQVIA HOLDINGS INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 230.4 USD | -0.31% |
|
-6.18% | -0.53% |
| Apr. 10 | Lupin Launches Generic Version of Oracea (Doxycycline Capsules) in US | MT |
| Apr. 08 | Iqvia, Salesforce Collaborate to Accelerate Life Sciences Cloud Development | MT |
Chart calendar Iqvia Holdings Inc.
57.YVZ7GUzQGUTGxjOgrJE0iY_SGPaXLNzPeUhi2kGa8cY.CSZDTRSkUWmyp33r2-Rl69zrVbrBXLalChgOqizKxfE1bj5uC7tjMKSlYg~e24dd89672fc6a322968979e51881b33
Upcoming events on Iqvia Holdings Inc.
Past events on Iqvia Holdings Inc.
| Today 09:00 am | Annual General Meeting |
| 2024-03-13 09:30 am | Barclays Global Healthcare Conference |
| 2024-02-29 09:30 am | Citi Unplugged Medtech and Life Sciences Access Day |
| 2024-02-14 09:00 am | Q4 2023 Earnings Call |
| 2024-02-14 07:00 am | Q4 2023 Earnings Release |
| 2023-11-29 10:50 am | Evercore ISI HealthCONx Conference |
| 2023-11-01 09:00 am | Q3 2023 Earnings Call |
| 2023-11-01 07:00 am | Q3 2023 Earnings Release |
| 2023-09-13 10:50 am | Baird Global Healthcare Conference |
| 2023-09-12 11:30 am | Morgan Stanley Global Healthcare Conference |
| 2023-08-01 09:00 am | Q2 2023 Earnings Call |
| 2023-08-01 07:00 am | Q2 2023 Earnings Release |
| 2023-04-27 09:00 am | Q1 2023 Earnings Call |
| 2023-04-27 07:00 am | Q1 2023 Earnings Release |
| 2023-04-18 09:00 am | Annual General Meeting |
| 2023-03-15 09:30 am | Barclays Global Healthcare Conference |
| 2023-02-10 09:00 am | Q4 2022 Earnings Call |
| 2023-02-10 07:00 am | Q4 2022 Earnings Release |
| 2022-11-08 12:10 pm | Credit Suisse Healthcare Conference |
| 2022-10-26 09:00 am | Q3 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 11 088 11 042 0.42% | 11 359 11 202 1.4% | 13 874 13 830 0.32% | 14 410 14 387 0.16% | 14 984 14 910 0.5% | 15 530 |
|
EBITDA Million USD | Released Forecast Spread | 2 400 2 401 -0.04% | 2 384 2 347 1.59% | 3 022 2 993 0.98% | 3 346 3 342 0.13% | 3 569 3 566 0.08% | 3 762 |
|
EBIT Million USD | Released Forecast Spread | 2 112 2 112 -0% | 2 030 1 990 2.03% | 2 591 2 537 2.11% | 2 779 2 846 -2.36% | 3 050 3 028 0.72% | 3 148 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 352 429 -18.04% | 373 392 -4.84% | 1 128 1 089 3.61% | 1 363 1 540 -11.51% | 1 459 1 518 -3.9% | 1 697 |
|
Net income Million USD | Released Forecast Spread | 191 306 -37.67% | 279 331 -15.7% | 966 922 4.75% | 1 091 1 219 -10.47% | 1 358 1 226 10.77% | 1 327 |
|
EPS USD | Released Forecast Spread | 0,96 1,53 -37.36% | 1,43 1,70 -16.02% | 4,95 4,73 4.6% | 5,72 6,35 -9.97% | 7,29 6,53 11.7% | 7,30 |
| Announcement Date | 12/02/20 | 10/02/21 | 15/02/22 | 10/02/23 | 14/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3 636 3 612 0.66% | 3 568 3 539 0.82% | 3 541 3 493 1.36% | 3 562 3 545 0.47% | 3 739 3 713 0.71% | 3 652 3 608 1.22% | 3 728 3 708 0.53% | 3 736 3 777 -1.08% | 3 868 3 797 1.88% | 3 705 | 3 817 | 3 899 | 4 101 | 3 984 |
|
EBITDA Million USD | Released Forecast Spread | 828 805 2.87% | 812 804 1% | 800 796 0.48% | 814 808 0.71% | 920 913 0.75% | 851 849 0.21% | 864 860 0.47% | 888 886 0.21% | 966 963 0.32% | 864 | 913 | 950 | 1 030 | 954 |
|
EBIT Million USD | Released Forecast Spread | 704 687 2.4% | 691 683 1.14% | 682 673 1.31% | 694 686 1.18% | 712 783 -9.11% | 721 723 -0.25% | 737 726 1.56% | 747 753 -0.86% | 821 821 0.02% | 728 | 775 | 802 | 876 | 805 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 376 331 13.59% | 400 404 -1.07% | 328 406 -19.21% | 360 373 -3.57% | 275 472 -41.68% | 362 363 -0.33% | 375 368 1.79% | 349 379 -7.98% | 373 430 -13.34% | 359 | 403 | 432 | 505 | 409 |
|
Net income Million USD | Released Forecast Spread | 318 272 16.99% | 325 298 8.89% | 256 281 -8.86% | 283 271 4.6% | 227 354 -35.88% | 289 290 -0.3% | 297 283 4.93% | 303 294 3.04% | 469 333 40.65% | 284 | 318 | 341 | 401 | 325 |
|
EPS USD | Released Forecast Spread | 1,63 1,40 16.71% | 1,68 1,57 6.77% | 1,34 1,47 -9.04% | 1,49 1,47 1.03% | 1,20 1,87 -35.81% | 1,53 1,52 0.63% | 1,59 1,50 6.2% | 1,63 1,58 3.37% | 2,54 1,77 43.5% | 1,48 | 1,72 | 1,85 | 2,15 | 1,81 |
| Announcement Date | 15/02/22 | 27/04/22 | 21/07/22 | 26/10/22 | 10/02/23 | 27/04/23 | 01/08/23 | 01/11/23 | 14/02/24 | - | - | - | - | - |
More events
Past sector events for Iqvia Holdings Inc.
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
| 2024-03-27 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q4 2023 Earnings Release |
| 2024-03-27 10:25 am | PHARMARON BEIJING CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IQV Stock
- Calendar Iqvia Holdings Inc.
